$17.60
+0.29 (+1.68%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-37.67%
1Y
-36.46%
YTD
-34.77%
Open$17.59
Previous Close$17.31
Day High$17.81
Day Low$16.82
52W High$42.50
52W Low$14.19
Volume—
Avg Volume2.48M
Market Cap5.22B
P/E Ratio153.64
EPS$0.11
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$25.57
Below
RSI (14)
21.6
Oversold
Analyst Ratings
Strong Buy
16 analysts
Price Target
+75.7% upside
Current
$17.60
$17.60
Target
$30.92
$30.92
$20.23
$30.92 avg
$48.05
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.37B | 1.64B | 1.52B |
| Net Income | -115,107,575 | 316.28M | 306.08M |
| Profit Margin | -8.4% | 19.3% | 20.1% |
| EBITDA | 42.77M | 415.16M | 429.14M |
| Free Cash Flow | — | 185.08M | 215.40M |
| Rev Growth | — | +14.2% | +10.8% |
| Debt/Equity | 0.66 | 0.26 | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |